Cargando…
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10
OBJECTIVE: There are no validated approaches to predict benefit from adjuvant chemotherapy for resected patients with non-small-cell lung cancer (NSCLC). The aim of this study was to translate a 15-gene mRNA expression profile published by Zhu et al, shown to be prognostic and predictive of benefit,...
Autores principales: | Grieve, Stacy, Ding, Keyue, Moore, Jonathan, Finniss, Mathew, Ray, Ayush, Lees, Miranda, Hossain, Faisal, Murugesan, Alli, Agar, Jane, Acar, Cenk, Taylor, James, Shepherd, Frances A, Reiman, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174014/ https://www.ncbi.nlm.nih.gov/pubmed/32220948 http://dx.doi.org/10.1136/esmoopen-2020-000679 |
Ejemplares similares
-
Semi-supervised peak calling with SPAN and JBR genome browser
por: Shpynov, Oleg, et al.
Publicado: (2021) -
Editorial and research agenda: JBR special issue on business model innovation in social purpose organizations
por: Weerawardena, Jay, et al.
Publicado: (2021) -
TAZ upregulates MIR‐224 to inhibit oxidative stress response in multiple myeloma
por: Abegunde, Samuel O., et al.
Publicado: (2023) -
Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
por: Alfarra, Helmi, et al.
Publicado: (2020) -
Haemophilus parainfluenzae Pyogenic Liver Abscess Associated With Cholangiocarcinoma
por: Finniss, Mathew C, et al.
Publicado: (2022)